Navigation Links
Novel antibiotic dressing developed for improved wound healing

Hospital acquired infections, remains a significant health issue to be tackled and the number of mortality as a result of this keeps increasing every year. Antibiotic-resistant // bacteria, such as methicillin-resistant staphylococcus aureus and vancomycin-resistant enterococci, cause about 70 percent of such infections.

In an attempt to reduce the incidence of such events, researchers have now come up with a unique wound dressing with antibiotic coating. This microbicidal coating can be chemically bonded to gauze bandages, socks and even hospital bedding and gowns. The coating is effective against the above-mentioned forms of antibiotic resistant bacteria in hospital settings.

The coating not only prevents bacterial attack and colonization but also prevents resistance being developed. The coating comprises thousands of nitrogen clusters that permanently bond to substances such as gauze and fabric.

The coating also does what it was created to do - aids healing. When added to gauze, it makes the material super absorbent, pulling excess moisture away from the sore. Other dressings use a process that allows molecules to diffuse into the air and into the wound, which can slow healing and increases the chance germs will develop resistance.

The antibiotic substance has to be efficiently mass-produced in such a way it can be permanently made adherent to wound dressings or perhaps it could even be applied to ready-to-wear clothing. However, large-scale industrial manufacturing would be required to produce huge quantities of these commodities.

Other potential uses of the coating would be designing of special clothing for soldiers in the field who often don't have time to change or shower, manufacturing of hospital gowns and bedding to prevent spread of bugs.

Page: 1

Related medicine news :

2. Novel biopsy technique for prostate cancer
3. Novel computer model for breast cancer
4. Novel research on liver cancer
5. Novel way to fight cancer
6. Novel test for bowel cancer
7. Novel Anti-Neutrophilic Effect produced by Salmeterol in mild asthma patients
8. Novel Therapy for Chronic Problem
9. Blood Sugar Kept In Control By Novel Protein
10. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
11. Novel drug holds promise for treatment of Rheumatoid Arthritis
Post Your Comments:

(Date:11/30/2015)... ... November 30, 2015 , ... ... of the leading plastic surgery practices in Florida, is proud to announce that ... for surgical innovations giant Ethicon Inc., a Johnson & Johnson Company. , Ethicon ...
(Date:11/30/2015)... (PRWEB) , ... November 30, ... ... (AIS) is pleased to announce the speakers for “Value-Based Payer-Provider Partnerships: Three ... learned from three innovative value-based care arrangements: Essentia Health and UCare, MissionPoint ...
(Date:11/30/2015)... ... , ... Sikka Software announced today that they are showcasing the Sikka Software ... complex business decisions by providing the tools and information they need to grow their ... procedures customized by zip code. , The Sikka Software Ecosystem includes over 32 ...
(Date:11/30/2015)... ... November 30, 2015 , ... The successful filing of an Investigational ... it is so important to this key industry segment, Regis Technologies has decided to ... on December 4th at 11am EST. , Federal law does not allow new drugs ...
(Date:11/30/2015)... EMIGSVILLE, PA (PRWEB) , ... November 30, 2015 ... ... (CCMS) software provider, has verified that their Vasont Universal Integrator (VUI) extension unites ... handle creating, editing, and managing content as a continuous process with the latest ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)...  Hanger, Inc. (NYSE: HGR ) (the "Company") ... of its previously announced consent solicitation (as amended and ... principal amount 7⅛% Senior Notes due 2018 (the "Notes") ... payable pursuant to the Consent Solicitation, (ii) the proposed ... expiration date of the Consent Solicitation.    ...
(Date:11/30/2015)... 2015  Novartis will demonstrate the strength of its ... American Society of Hematology (ASH) Annual Meeting. Presentations will ... as supportive care, including key findings in rare and ... The ASH Annual Meeting will be held December 5-8 ... Novartis Oncology . "We will be presenting encouraging overall ...
(Date:11/30/2015)... , Nov. 30, 2015   VolitionRx Limited (NYSE ... diagnostic tests for a broad range of cancer types and ... LD Micro Conference, which will be held December 1 - 3 ... from VolitionRx will be David Kratochvil , Chief Financial ... of Investor Relations. ® blood-based tests for ...
Breaking Medicine Technology: